10:09 <00226><00156><00655> - Joint Announcement & Resumption (4) acquisition of the Property does not have any significant impact on the liquidity position of Lippo and its subsidiaries as a whole. INFORMATION ON HCL, LCR, LIPPO AND THE SELLER The principal activity of each of Lippo and LCR is investment holding. LCR is Lippo's principal subsidiary. The principal activities of the subsidiaries of LCR are investment holding, property investment and development, food businesses, property management, fund management, underwriting, insurance, corporate finance, securities broking, securities investment, treasury investment, money lending, commercial banking and other financial services. The principal activity of HCL is investment holding. Its subsidiaries are principally engaged in investment holding, property investment and development, fund management, underwriting, insurance, corporate finance, securities broking, securities investment, treasury investment, money lending, commercial banking and other financial services. So far as the respective boards of directors of HCL, LCR and Lippo are aware after having made all reasonable enquiries, the principal activity of the Seller is property investment. GENERAL Each of LCR, HCL and Lippo will, within 21 days after publication of this announcement, send a circular to their respective shareholders in accordance with rules 14.38 and 14.40 of the Listing Rules. Trading in the shares of each of Lippo, HCL and LCR were suspended from 9:30 a.m. on 24th January, 2005 at the request of Lippo, HCL and LCR pending the publication of this announcement and applications have been made to the Stock Exchange for the resumption of trading of the shares of each of Lippo, HCL and LCR from 9:30 a.m. on 28th January, 2005. By Order of the Board LIPPO LIMITED Davy Lee Secretary By Order of the Board LIPPO CHINA RESOURCES LIMITED Millie Luk Secretary By Order of the Board HONGKONG CHINESE LIMITED Andrew Hau Secretary Hong Kong, 27th January, 2005 * For identification purpose only As at the date of this announcement, the board composition of each of Lippo, LCR and HCL is as follows: LIPPO Non-executive Director: Mr. Leon Nim Leung Chan Executive Directors: Mr. Stephen Riady Mr. John Luen Wai Lee Mr. Jark Pui Lee Mr. David T. Yeh